Grants and Contributions:
Title:
AI-Based Planning of Transarterial Radioembolization (TARE)
Agreement Number:
1034140
Agreement Value:
$328,580.00
Agreement Date:
Jun 2, 2025 - May 31, 2026
Description:
This project aims at creating an AI-powered software system for planning transarterial radioembolization (TARE) treatments of liver tumors. The system will automatically segment liver tissue, tumors, and vascular structures from medical images routinely acquired by interventional radiologists. Building on our existing Elucis platform and previous IRAP-funded AI capabilities, the system will aid in the calculation of metrics critical to the TARE treatment workflow.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Ottawa, Ontario, CA K1Y 2C5
Reference Number:
172-2025-2026-Q2-1034140
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
718021710
Recipient Type:
For-profit organization
Recipient's Legal Name:
Realize Medical Inc.
Federal Riding Name:
Ottawa Centre
Federal Riding Number:
35075
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
511211